LIC announced on Thursday that it had sold 2 percent of its stake in Sun Pharma for Rs 4,699 crore in an open market transaction.
Following the share sale, there is a decrease of 2 percent decline in holding between July 22, 2022, and September 13, 2023.
In a regulatory filing, LIC stated, “Corporation’s shareholding in Sun Pharma has diluted from 12,05,24,944 to 7,22,68,890 equity shares decreasing its shareholding from 5.023 percent to 3.012 percent of the paid-up capital of the said company”.
“The shares were sold at an average price of Rs 973.80 per share during the period through an open market sale in an ordinary course of transaction”, LIC added.
Sun Pharma manufactures, develops, and markets a diverse range of branded and generic formulations, as well as Active Pharma Ingredients (APIs).
LIC, the country’s largest state-owned insurer, finished at Rs 660.80 per share on BSE, up 0.27 percent. Sun Pharma shares closed 0.8 percent higher at Rs 1,143.60.
Also read: Maruti Suzuki Collaborates With Indian Bank To Offer Dealers Financing Options
The Supreme Court has granted a major relief to the Rajasthan government by upholding the…
The Supreme Court has expressed concern over the rising tendency to register rape cases based…
Adani Ports & Special Economic Zone set a national record by handling 450 MMT of…
SC issues notice to UP govt, Neelam Katara on Vikas Yadav’s interim bail plea in…
The SC expressed displeasure over Telangana Chief Minister A Revanth Reddy’s remarks regarding the disqualification…
JIH President Syed Sadatullah Husaini condemns the Waqf Amendment Bill for singling out Muslims and…